spacer
Life Extension
 

Life Extension is a global authority on nutrition, health and wellness

as well as a provider of scientific information on anti-aging supplements and therapies. We supply only the highest quality nutritional supplements, including minerals, vitamins, herbs and hormones.

Access your account today: Login        Learn about our membership benefits

translation by SYSTRAN  
Life Extension Pharmacy - Transfer Your Prescription Today and Get a $25 Gift Card
 
Life Extension Magazine

Page: 12

LE Magazine November 2003
Fish And N-3 Fatty Acids Reduce Risk Of Alzheimer’s Disease

A new study, from the Rush-Presbyterian, St. Lukes Medical Center, in Chicago, shows that people who consumed at least one serving of fish a week dramatically reduced their risk of Alzheimer’s disease, compared to those who rarely or never ate fish. Dietary intake of omega-3 fatty acids had a similar risk-lowering effect.1

The prospective study involved 815 Chicago nursing home residents, aged 65 to 94, unaffected by Alzheimer’s disease (AD). Participants completed a dietary frequency questionnaire that included 4 seafood items: Tuna fish sandwich, fish sticks/fish cakes/fish sandwich, fresh fish as a main dish, and shrimp/crab/lobster. Total omega-3 fatty acid (n-3) intake was calculated as the sum of alpha linolenic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).2

After an average follow up of 3.9 years, 131 of the participants were diagnosed as having AD. The incidence of AD was inversely associated with fish consumption. Persons who ate fish once a week or more shaved a 60% lower risk of AD, compared to those who rarely or never ate fish (fresh fish as the main course was the type consumed most frequently). A similar inverse association was found with total n-3 fatty acid intake. Persons who consumed the highest amounts (median 1.75 g/day), had a 70% reduced likelihood of having AD, compared to those with the lowest intake (median 0.9 g/day).3

Of the marine fatty acids (EPA, DHA) only DHA was protective, reducing the risk of AD by 60%, in age- adjusted calculations. DHA is the most abundant fatty acid in brain phospholipids, present in high amounts in the cerebral cortex, mitochondria, and neural connections. EPA had little effect on AD risk, as intake was low, with 40% of participants consuming 0 g/day. (In a 24 hour dietary recall, more than 90% of 234 participants said they ate fish low in fat.) Dr. Martha Claire Morris, the lead investigator, conceded that one cannot rule out a protective effect of EPA, obtained by intake of fatty fish or fish oil supplements. Intake of linolenic acid (found mainly in vegetable oil-based salad dressing and nuts) was protective in persons carrying a gene that has been linked to risk of AD.

The study adds to previous findings on the relationship between fish consumption, n-3 fatty acids and brain health. A Canadian study showed that n-3 fatty acid levels in plasma phospholipids of patients with AD and other cognitive disorders were lower compared to levels in age-matched controls; a large study in France, of people aged 68 and older, showed that “elderly people who eat fish at least once a week are at a lower risk of developing dementia, including AD.” The authors suggested that “in addition to providing vascular protection, the fatty acids contained in fish oils could reduce inflammation in the brain.”

An accompanying editorial to the Chicago report, suggested that a healthy diet containing antioxidant-rich foods and fish is likely to lower the risk of AD and other ailments, and that fish oil supplements can be good sources of omega-3 fatty acids.

—Carmia Borek, Ph.D.

References

1. Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003 Jul;60(7):940-6.

2. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renauds. Fish, meat and risk of dementia: cohort study. BMJ. 2002 Oct 26;325(7370):932-3.

3. Conquer JA, et al. Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment. Lipids. 2000 Dec;35(12):1305-12.

Continued on Page 2 of 2

column header
Sign Up for Life Extension's FREE email newsletter Health Concerns
Products
Abstracts
spacer
Super Ubiquinol CoQ10
Network Solutions SecuredBetter Business Bureau Accredited BusinessLife Extension Track Record5-Star Rated Fish Oil SupplementLife Extension Royal Treatment Customer ServiceLearn About our VIP AutoShip ProgramCustomer Satisfaction GuaranteedDirect Marketing Association Member

Home | Membership | Products | Magazine | Health Concerns | News | About Us | Legal Notices | Privacy Policy | Site Map


All Contents Copyright © 1995-2009 Life Extension Foundation® All rights reserved.

*These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. You should not stop taking any medication without first consulting your physician.